Vertex Pharmaceuticals Inc (VRTX)

410.06 -0.59 (-0.14%) USD  |  NASDAQ  |  Dec 27, 09:43
More

Vertex Pharmaceuticals Total Long Term Debt (Quarterly): 0.00 for Sept. 30, 2024

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Debt Definition

View Total Long Term Debt Definition
Start Trial

Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Eli Lilly and Co 31.12B
Gilead Sciences Inc 23.25B
Bristol-Myers Squibb Co 49.75B
Pfizer Inc 66.62B
PTC Therapeutics Inc 285.11M